Zurich Cantonal Bank’s iRadimed IRMD Stock Holding History

Zurich Cantonal Bank’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$454K	Sell	4,748 -784	-14%	-$71.4K	﹤0.01%	1997
2026 Q1	$533K	Buy	+5,532	New	+$553K	﹤0.01%	1799
2025 Q4	–	Sell	-5,557	Closed	-$477K	–	3023
2025 Q3	$395K	Buy	+5,557	New	+$370K	﹤0.01%	1867
2025 Q2	–	Sell	-7,815	Closed	-$410K	–	2597
2025 Q1	$410K	Sell	7,815 -787	-9%	-$44.2K	﹤0.01%	1717
2024 Q4	$473K	Buy	8,602 +3,632	+73%	+$191K	﹤0.01%	1663
2024 Q3	$250K	Buy	+4,970	New	+$229K	﹤0.01%	1992
2022 Q4	–	Sell	-3,085	Closed	-$93K	–	2877
2022 Q3	$93K	Sell	3,085 -11,768	-79%	-$410K	﹤0.01%	2283
2022 Q2	$504K	Buy	+14,853	New	+$532K	﹤0.01%	1223

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zurich Cantonal Bank's IRMD Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its iRadimed (IRMD) stake by 14% in Q2 2026, selling an estimated $71.4K and leaving 4,748 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.

Zurich Cantonal Bank first reported a position in IRMD in Q2 2022 and has held it in 8 quarters since. The position peaked at $533K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Zurich Cantonal Bank held 4,748 shares of iRadimed worth $454K as of Q2 2026.
Zurich Cantonal Bank sold 784 iRadimed shares in Q2 2026, an estimated $71.4K.
iRadimed made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1997 holding.
Zurich Cantonal Bank first reported a position in iRadimed in Q2 2022 and has held it in 8 quarters since.
Zurich Cantonal Bank's iRadimed position peaked at $533K in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.